Clinical Trial Update: The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Topically Dissolved Oxygen (TDO) to reduce signs of photodamage. The study includes rosacea, acne vulgaris, atopic derm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Atopic Dermatitis
• Rosacea
• Seborrheic Dermatitis

Drugs mentioned

• Topically Dissolved Oxygen (TDO) (topically dissolved oxygen)

Snippet

Sponsor: Aria Aesthetics Inc. | Conditions: Rosacea, Acne Vulgaris | Phase 2 | Status: COMPLETED